This HTML5 document contains 50 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
schemahttp://schema.org/
rdfshttp://www.w3.org/2000/01/rdf-schema#
skoshttp://www.w3.org/2004/02/skos/core#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
n9http://dx.doi.org/10.4088/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q55887217
rdf:type
wikibase:Item
schema:description
наукова стаття, опублікована в листопаді 2002 article scientifique publié en novembre 2002 im November 2002 veröffentlichter wissenschaftlicher Artikel wetenschappelijk artikel
p:P577
wds:Q55887217-447BA916-B28A-43E4-846B-6E6BA6CC8B60
wdt:P577
2002-11-15T00:00:00Z
p:P2093
wds:Q55887217-D8DEA6FD-3534-452A-9367-50C4A0F97CE7 wds:Q55887217-B998CE3C-7009-4B09-A00B-71BA665666AD wds:Q55887217-A15D8F62-4E7D-4FCF-883C-A197B94A5C27 wds:Q55887217-8BF38D60-3AC5-4DF4-9F1B-0601176A2E99 wds:Q55887217-96149130-7AE7-4C8D-8135-23681B28FC91 wds:Q55887217-F2E97F49-C26C-4A81-9952-496AFF4D951F wds:Q55887217-59F521DA-B8C2-4795-8D74-92D15D9131FC wds:Q55887217-272C8288-3994-469D-82B5-7C24E18EDD47 wds:Q55887217-0FB96FDF-3DC6-4537-A77F-D7EBC1EDCB51
wdt:P2093
Olivier Sol Eric Sermet Anne Danniau Jean-Paul Macher Emmanuelle Corruble Thierry Bougerol Dominique Servant Michel Faruch Christian Spadone
rdfs:label
Efficacy and Safety of Hydroxyzine in the Treatment of Generalized Anxiety Disorder Efficacy and Safety of Hydroxyzine in the Treatment of Generalized Anxiety Disorder
skos:prefLabel
Efficacy and Safety of Hydroxyzine in the Treatment of Generalized Anxiety Disorder Efficacy and Safety of Hydroxyzine in the Treatment of Generalized Anxiety Disorder
schema:name
Efficacy and Safety of Hydroxyzine in the Treatment of Generalized Anxiety Disorder Efficacy and Safety of Hydroxyzine in the Treatment of Generalized Anxiety Disorder
p:P50
wds:Q55887217-0DF211F6-CF76-4799-988A-B6D6BE79FD52
wdt:P50
wd:Q83120424
p:P1476
wds:Q55887217-1327F142-AC4A-4415-9006-6F30AACE7A92
wdt:P1476
Efficacy and Safety of Hydroxyzine in the Treatment of Generalized Anxiety Disorder
p:P304
wds:Q55887217-B777748B-BC5C-4BB5-914E-21A84BA80662
wdt:P304
1020-1027
p:P31
wds:Q55887217-F142D2A8-213D-48DA-B041-BEB1E4A052D8
wdt:P31
wd:Q13442814
p:P921
wds:Q55887217-38D48793-BF4C-420C-B9A7-86F47BB10683
wdt:P921
wd:Q845224
p:P1433
wds:Q55887217-3A9E5415-C030-444C-B775-BA8F9D7CB713
wdt:P1433
wd:Q7743563
p:P433
wds:Q55887217-A98A7E20-543C-4D9F-9318-F0D443C555D2
p:P478
wds:Q55887217-E8649EB3-6A35-4ADD-82EF-B7EE0FA293F9
wdt:P433
11
wdt:P478
63
p:P356
wds:Q55887217-2A6EFF7A-FD72-4621-944E-2D1B9545B4AB
wdtn:P356
n9:JCP.V63N1112
wdt:P356
10.4088/JCP.V63N1112